Article
HbE/β-thalassemia: basis of marked clinical diversity.
Hematology/oncology clinics of North America - 1 Dec 2010
Olivieri Nancy F, Pakbaz Zahra, Vichinsky Elliott
Abstract excerpt
Hemoglobin E thalassemia accounts for about one-half of all cases of severe beta thalassemia. There is marked variability in its clinical severity ranging from an asymptomatic to a transfusion-dependent phenotype. The phenotypic variability and inadequate longitudinal data present challenges in determining the optimal management of patients. This article summarizes findings on the natural history of Hemoglobin E...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
